Dominari Holdings Inc. — Form 10-Q Summary
Reporting period: Quarter and six months ended June 30, 2023. Financial statements are unaudited; amounts below are in U.S. dollars. The company is shifting its primary focus from biotechnology toward financial services.
Business context and reporting period
Dominari operates two reportable segments: Dominari Securities, its broker-dealer and investment-advisory business, and Legacy AIkido Pharma, which manages legacy biotechnology assets and investments. In March 2023, Dominari Financial completed its acquisition of the remaining 80% of Fieldpoint Private Securities (FPS), renamed Dominari Securities. Aikido Labs is winding down its historical biotechnology pipeline.
Financial performance and position
| Metric | Q2 2023 | Six months 2023 | Comparable 2022 |
|---|---|---|---|
| Revenue | $71,000 | $71,000 | $0 |
| Operating expenses | $9.082 million | $12.916 million | $2.298 million / $6.101 million |
| Operating loss | $9.011 million | $12.845 million | $2.298 million / $6.101 million |
| Net loss | $8.663 million | $12.425 million | $5.077 million / $8.612 million |
| Loss per share, basic and diluted | $1.79 | $2.45 | $1.18 / $2.42 |
| Operating cash used | Not separately stated | $13.913 million | $5.850 million |
At June 30, 2023, cash and cash equivalents were $3.598 million; marketable securities were $20.675 million; and deposits with the clearing broker were $7.082 million. Total assets were $67.695 million, total liabilities $5.917 million, and stockholders’ equity $61.778 million. Current assets of $38.422 million exceeded current liabilities of $2.658 million; management reported working capital of approximately $35.7 million.
The company reported $3.612 million of operating lease liabilities, including $353,000 current and $3.259 million long-term. No other borrowings are identified in the supplied filing text. Long-term investments were $23.178 million and notes receivable at fair value totaled $7.961 million, both subject to valuation assumptions.
Material changes versus the prior comparable period
- Revenue began to be reported in 2023, totaling $71,000 from underwriting, commissions, and other revenue; the filing reports no revenue in the 2022 periods.
- Q2 operating expenses rose to $9.082 million from $2.298 million; six-month expenses rose to $12.916 million from $6.101 million. Management attributes the increase principally to higher compensation as financial-services operations were established and expanded.
- Dominari Securities reported Q2 revenue of approximately $71,000 and a net loss of approximately $7.7 million. Its loss primarily reflected approximately $5.4 million of bonus and employee compensation and $0.9 million of professional services.
- Six-month cash used in operations increased to $13.913 million from $5.850 million. Investing activities used $14.724 million, including marketable-security purchases and the FPS acquisition; financing activities used $939,000, mainly for share repurchases.
- Marketable securities generated gains of $400,000 in Q2 and $335,000 for the six months, compared with losses of $2.239 million and $2.736 million, respectively, in 2022. These results reflect market movements and securities transactions.
Outlook, risks, contingencies, and unusual items
- Management believes cash, cash equivalents, and marketable securities, together with anticipated operating cash flow, are sufficient for at least the next 12 months. It also says additional capital may be needed sooner if cash flows, plans, expenses, or market conditions worsen. Potential debt financing could increase debt-service burdens; equity financing could dilute shareholders.
- The company continues to incur administrative and public-company costs in excess of non-financing revenue. Financial-services growth, revenue generation, and execution of the strategic transition remain significant uncertainties.
- Management cites market volatility and macroeconomic uncertainty as affecting securities and investment valuations. Notes receivable and certain investments use Level 3 inputs and require significant judgment; the filing records a $212,000 unrealized loss on a note receivable for the six months.
- On June 27, the company granted Soo Yu 1,033,591 fully vested shares with stated fair value of approximately $2.7 million; 503,876 shares were withheld for approximately $1.3 million of taxes. The filing also reports $2.675 million of stock-based compensation for the first half.
- The company reported no material active or pending legal proceedings and no defaults upon senior securities. Dominari Securities reported net capital of approximately $7.3 million, about $7.2 million above its $100,000 regulatory minimum. Management concluded disclosure controls were effective at period-end.
Important facts for investors to verify
- Whether Dominari Securities can materially increase revenue and improve on its reported Q2 loss as operations mature.
- Cash burn, liquidity available for operations, and the basis for management’s 12-month funding assessment, including the usability of broker deposits and marketable securities.
- Valuation, repayment status, and collectability of Level 3 notes receivable and private-company investments.
- The economics and integration progress of the FPS acquisition, including its operating costs and future revenue contribution.
- Share-count and dilution details: the cover reports 5,345,312 shares outstanding as of August 8, while the June 30 balance sheet reports 5,285,164 shares outstanding; confirm the current outstanding count and the effect of grants, withholding, and repurchases.